Evaluation of pharmaceutical services in risk management in the drug utilization in public hospitals of the Federal District, Brazil

• Autor(a) principal: Lima, Rodrigo Fonseca
• Data de Publicação: 2020
• Outros Autores: Toledo, Maria Inês de, Pereira, Izabel Cristina Ferreira Schult, Silva, Paulo Henrique Dourado, Naves, Janeth de Oliveira Silva
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Vigilância Sanitária em Debate
• Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1415
• topic: Health Services Research; Patient Safety; Risk Management; Hospital Pharmacy Service; Pharmacovigilance; Avaliação de Serviços de Saúde; Segurança do Paciente; Gestão de Riscos; Serviço de Farmácia Hospitalar; Farmacovigilância

Introduction: The frequency of adverse events is high in hospitals and this context supported the elaboration of goals, whose execution involves the hospital pharmacy (HP). Objective: To evaluate HP’s participation in risk management in medication use in 15 public hospitals in the Federal District (Brazil). Method: Cross-sectional study whose data collection was performed from May to November 2016 and involved hospital characterization and hierarchization, HP evaluation according to indicators related to risk management in the use of medicines and calculation of percentages of compliance with the activities provided for in the indicators (outcome variable) with subsequent correlation to variables that could influence their results through linear regression. Results: The average proportion of items presented in risk management indicators was 28.3%. Less than half of the active beds had an individualized dose as drug delivery system. There were 48 reports of pharmacovigilance in the period. The parameters that influenced the outcome variable were: staff training schedule, HP hours with pharmacist, active beds with individualized dose, and percentage of compliance with pharmaceutical services (p < 0.05). Conclusions: The results refer to the need for adequacy and monitoring of services aiming at rational interventions that seek to make the process of drug use safer, by implementing the management models related to HP.